Prevalence of ABO Blood Grouping among Hemodialysis Patients in Dubai

Fakhriya      Alalawi; Kashif      Gulzar; Waleed   Mohamed   Galaleldin; Amna      Alhadari

Abstract

Background: Beyond their vital role in blood transfusion, ABO antigens were speculated to be involved in developing various human illnesses, including infectious, neoplastic, cardiovascular, and many others. Many researchers attempted to highlight the relationship between kidney disease and ABO phenotypes. The majority of these reports showed a predominance of blood group O antigen among patients with chronic kidney disease, while few had opposed these findings. We aimed in this study to elaborate on blood group typing among our hemodialysis patients and whether it has a prognostic effect on the overall mortality.

Methods: This is an observational, cross-sectional, retrospective study among chronic adult hemodialysis patients being dialyzed at Dubai Hospital over the past six months, from Jan 2021 till June 2021. The patient's demographic characteristics (age, sex, etiology of chronic kidney disease, medical comorbidities, and blood groups) were retrieved using an electronic hospital medical record system.

Results: Our study population constituted 224 hemodialysis patients; their mean age was 55.4 years (16-94 years), 83.6% were UAE nationals, and 59.8% were males. Diabetic nephropathy was the etiology of end-stage kidney disease in 46%. ABO blood group distribution among our study population was as follows; group O was the commonest (45%), followed by group B positive (23%) and A Positive (20.9%). Among the UAE national patients group, O+ constitutes 46.9%, followed by B+ in 24%, and A+ in 21%. Nevertheless, group O+ was still the commonest among the nonnational hemodialysis patients in 37.7%, A+ in 28.8%, and B+ in 24.4%. Additionally, group O-positive was the predominant group among all diabetic dialysis patients (47%). Nine patients died during the study period of different causes; out of them, 4 patients (44.4%) had group O positive.

Conclusion: Blood group O was the commonest blood group among our hemodialysis patients. Additionally, it was the commonest group in all diabetic dialysis patients. More studies from Arab countries are needed to comprehend the relationship between ABO blood phenotypes and kidney disease and whether certain blood groups have any role in a patient's progression to ESKD.

Keywords: ABO group, HD: hemodialysis, ESKD: End-Stage Kidney Disease, Mortality, Blood group phenotype, Diabetic nephropathy.

[1]
van der Tol A, Lameire N, Morton RL, Van Biesen W, Vanholder R. An international analysis of dialysis services reimbursement. Clin J Am Soc Nephrol  2019; 14(1): 84-93.
 [http://dx.doi.org/10.2215/CJN.08150718] [PMID: 30545819]

[2]
Ali A. Demographics and key clinical characteristics of hemodialysis patients from the GULF cooperation council (GCC) participating in DOPPS. Nephrol Dial Transplant  2016; 31 (Suppl. 1): i279-97.

[3]
Wang J, Zhang L, Tang SC, et al. Disease burden and challenges of chronic kidney disease in North and East Asia. Kidney Int  2018; 94(1): 22-5.
 [http://dx.doi.org/10.1016/j.kint.2017.12.022] [PMID: 29573819]

[4]
Alalawi F, Ahmed M, AlNour H, Noralla M, Alhadari A. Epidemiology of end-stage renal disease in Dubai: Single-center data. Saudi J Kidney Dis Transpl  2017; 28(5): 1119-25.
 [http://dx.doi.org/10.4103/1319-2442.215126] [PMID: 28937072]

[5]
Franchini M, Bonfanti C. Evolutionary aspects of ABO blood group in humans. Clin Chim Acta  2015; 444: 66-71.
 [http://dx.doi.org/10.1016/j.cca.2015.02.016] [PMID: 25689219]

[6]
Yang M, Xie J, Ouyang Y, et al. ABO blood type is associated with renal outcomes in patients with IgA nephropathy. Oncotarget  2017; 8(43): 73603-12.
 [http://dx.doi.org/10.18632/oncotarget.20701] [PMID: 29088730]

[7]
Landsteiner K. Zur kenntnis der antifermentativen, lytischen und agglutinierenden wirkungendes des blutserums und der lymphe. Zentralbl Bakteriol  1900; 27: 357-63.

[8]
Storry JR, Olsson ML. The ABO blood group system revisited: A review and update. Immunohematology  2009; 25(2): 48-59.
 [http://dx.doi.org/10.21307/immunohematology-2019-231] [PMID: 19927620]

[9]
Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med  2013; 51(8): 1545-53.
 [http://dx.doi.org/10.1515/cclm-2013-0168] [PMID: 23648637]

[10]
DHA urges rare blood type holders to donate. ARN News Centre 2021. Available from: 
                    https://www.arnnewscentre.ae/news/uae/dha-urges-rare-blood-type-holders-to-donate/

[11]
Blood type distribution by country - Wikipedia Enwikipediaorg 2021. Available from: 
                    https://en.wikipedia.org/wiki/Blood_type_distribution_by_country

[12]
Nakao M, Matsuo K, Ito H, et al. ABO genotype and the risk of gastric cancer, atrophic gastritis, and helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev  2011; 20(8): 1665-72.
 [http://dx.doi.org/10.1158/1055-9965.EPI-11-0213] [PMID: 21680535]

[13]
Wang Z, Zhang L, Guo Z, et al. A unique feature of iron loss via close adhesion of Helicobacter pylori to host erythrocytes. PLoS One  2012; 7(11): e50314.
 [http://dx.doi.org/10.1371/journal.pone.0050314] [PMID: 23185604]

[14]
Alkout AM, Blackwell CC, Weir DM. Increased inflammatory responses of persons of blood group O to Helicobacter pylori. J Infect Dis  2000; 181(4): 1364-9.
 [http://dx.doi.org/10.1086/315375] [PMID: 10753728]

[15]
Aird I, Bentall HH, Mehigan JA, Roberts JAF, et al. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus. BMJ  1954; 2(4883): 315-21.
 [http://dx.doi.org/10.1136/bmj.2.4883.315] [PMID: 13182205]

[16]
Garratty GE. Do blood groups have a biological role. Immunobiology of Transfusion Medicine  1994; 201-55.

[17]
Vojdani A. A potential link between environmental triggers and autoimmunity. Autoimmune Dis  2014; 2014: 437231.
 [http://dx.doi.org/10.1155/2014/437231] [PMID: 24688790]

[18]
Cserti CM, Dzik WH. The ABO blood group system and plasmodium falciparum malaria. Blood  2007; 110(7): 2250-8.
 [http://dx.doi.org/10.1182/blood-2007-03-077602] [PMID: 17502454]

[19]
Rowe JA, Handel IG, Thera MA, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci USA  2007; 104(44): 17471-6.
 [http://dx.doi.org/10.1073/pnas.0705390104] [PMID: 17959777]

[20]
Fry AE, Griffiths MJ, Auburn S, et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe plasmodium falciparum malaria. Hum Mol Genet  2008; 17(4): 567-76.
 [http://dx.doi.org/10.1093/hmg/ddm331] [PMID: 18003641]

[21]
Rowe JA, Opi DH, Williams TN. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Curr Opin Hematol  2009; 16(6): 480-7.
 [http://dx.doi.org/10.1097/MOH.0b013e3283313de0] [PMID: 19812491]

[22]
Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association between ABO and Rh blood groups and SARS-CoV-2 infection or severe COVID-19 illness: A population-based cohort study. Ann Intern Med  2021; 174(3): 308-15.
 [http://dx.doi.org/10.7326/M20-4511] [PMID: 33226859]

[23]
Coluk Y, Hizli O, Gunaydın S, Yildirim G, Baysal E, Ozgen Hergul G. Association of blood subgroups with PCR test positivity and lung involvement in patients With COVID-19. Cureus  2021; 13(3): e14172.
 [http://dx.doi.org/10.7759/cureus.14172] [PMID: 33936883]

[24]
Harris JB, Khan AI, LaRocque RC, et al. Blood group, immunity, and risk of infection with vibrio cholerae in an area of endemicity. Infect Immun  2005; 73(11): 7422-7.
 [http://dx.doi.org/10.1128/IAI.73.11.7422-7427.2005] [PMID: 16239542]

[25]
Liumbruno GM, Franchini M. Hemostasis, cancer, and ABO blood group: The most recent evidence of association. J Thromb Thrombolysis  2014; 38(2): 160-6.
 [http://dx.doi.org/10.1007/s11239-013-1027-4] [PMID: 24233389]

[26]
Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: A cohort study. Am J Epidemiol  2010; 172(11): 1280-5.
 [http://dx.doi.org/10.1093/aje/kwq299] [PMID: 20937632]

[27]
Rizzato C, Campa D, Pezzilli R, et al. ABO blood groups and pancreatic cancer risk and survival: Results from the PANcreatic Disease Research (PANDoRA) consortium. Oncol Rep  2013; 29(4): 1637-44.
 [http://dx.doi.org/10.3892/or.2013.2285] [PMID: 23403949]

[28]
Roy R, Ghosh B, Kar P. Investigating conformational dynamics of lewis Y oligosaccharides and elucidating blood group dependency of cholera using molecular dynamics. ACS Omega  2020; 5(8): 3932-42.
 [http://dx.doi.org/10.1021/acsomega.9b03398] [PMID: 32149220]

[29]
Dentali F, Sironi AP, Ageno W, et al. Non-O blood type is the commonest genetic risk factor for VTE: Results from a meta-analysis of the literature. Semin Thromb Hemost  2012; 38(5): 535-48.
 [http://dx.doi.org/10.1055/s-0032-1315758] [PMID: 22740183]

[30]
Dentali F, Sironi AP, Ageno W, Crestani S, Franchini M. ABO blood group and vascular disease: An update. Semin Thromb Hemost  2014; 40(01): 049-59.

[31]
Franchini M, Rossi C, Mengoli C, et al. ABO blood group and risk of coronary artery disease. J Thromb Thrombolysis  2013; 36(3): 286-7.
 [http://dx.doi.org/10.1007/s11239-012-0836-1] [PMID: 23096597]

[32]
Franchini M, Rossi C, Frattini F, et al. ABO blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: A single center survey. J Thromb Thrombolysis  2014; 38(1): 30-1.
 [http://dx.doi.org/10.1007/s11239-013-0995-8] [PMID: 24057604]

[33]
Zhong GC, Liu S, Wu YL, et al. ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in han chinese population. PLoS One  2019; 14(12): e0225792.
 [http://dx.doi.org/10.1371/journal.pone.0225792] [PMID: 31800606]

[34]
Hamed IA, Mandal AK, Parker D, Czerwinski AW, Mask DR, Wenzl JE. ABO blood groups and renal disease. Ann Clin Lab Sci  1979; 9(6): 524-6.
 [PMID: 518016]

[35]
Alanan U, Abbas A, Sulaiman I. Relationship between ABO blood group and end-stage renal disease in Latakia, Syria. Saudi J Kidney Dis Transpl  2017; 28(2): 445.
 [http://dx.doi.org/10.4103/1319-2442.202762] [PMID: 28352039]

[36]
Hassoon WA, Melconian AK. AL-Safar JM. Study the relationship between hemodialysis (HD) patients and their ABO blood grouping as well as screening of hemodialysis access-related bacterial infections. J Biol Sci  2013; 5(6): 291.

[37]
Alhawary SY, Al-Abdallat ME, Alamro SA, et al. Frequency of blood groups among a sample of patients with renal failure at royal medical services. Eur Sci J  2015; 11(33)

[38]
Bener A, Yousafzai MT. The distribution of the ABO blood groups among diabetes mellitus patients in Qatar. Niger J Clin Pract  2014; 17(5): 565-8.
 [http://dx.doi.org/10.4103/1119-3077.141418] [PMID: 25244264]

[39]
Silins J, Fortier L, Mao Y, et al. Mortality rates among patients with end-stage renal disease in Canada, 1981-86. CMAJ  1989; 141(7): 677-82.
 [PMID: 2790603]